Testosterone Litigation Looks Ahead to Status Conference in February, Bernstein Liebhard LLP Reports

Share Article

The Firm is monitoring updates in a federal litigation that will discuss issues related to testosterone lawsuits on February 13, 2015 in the Northern District of Illinois.

Free Case Review
We are currently investigating claims on behalf of men who allege serious cardiovascular side effects of low testosterone treatments.

A federal litigation that includes hundreds of testosterone lawsuits (http://www.testosteronelawsuithub.com/) is looking ahead to its next status conference, which is scheduled to take place in mid-February, Bernstein Liebhard LLP reports.

According to a Calendar posted on the Court’s website, parties involved in the proceeding will convene on February 13, 2015 at 1:30 p.m. There, members of the litigation, which is steadily moving forward in the U.S. District Court, Northern District of Illinois, will discuss matters related to testosterone lawsuits involving AndroGel, Testim, Axiron and other prescription therapy hormone treatments. Plaintiffs in these cases allege serious cardiovascular side effects due to their use of the medications. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)

“Our Firm is pleased to see continued progress in the federal multidistrict litigation involving testosterone lawsuits, as we are currently investigating claims on behalf of men who allege serious cardiovascular side effects of low testosterone treatments,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices and drugs. The Firm is currently offering free and confidential case reviews to men who were allegedly harmed by AndroGel, Axiron, Testim and other low testosterone medications.

Testosterone Lawsuits

According to court documents, the testosterone litigation has continued to grow since January 31, 2014, when the U.S. Food and Drug Administration (FDA) issued a public health alert that warned about the potential for low testosterone medications to cause strokes, heart attacks, deep vein thrombosis, pulmonary embolism and other serious cardiovascular problems. The federal regulator warned the public at this time that they would review these and other hormone medication safety risks. Nearly a year later, a growing number of plaintiffs whose lawsuits involve AndroGel, Testim, Axiron and other products, accuse drug manufacturers of failing to adequately warn about their association with life-threatening heart complications. They further accuse the companies of concealing information about these side effects, and claim that misleading marketing claims about testosterone products drove healthy men to take them.

Following the federal agency’s public health alert last January, a panel of advisors convened by the agency recommended that labeling on testosterone medications be adjusted to make clear their lack of proven effectiveness in treating low libido, fatigue, muscle loss and other symptoms men often experience as they age. Panelists also advised manufacturers of testosterone replacement therapies to conduct studies of their cardiovascular side effects.*

Men who allege serious cardiovascular side effects due to their use of prescription treatments may be eligible to receive compensation for injury-related damages. Learn more about the risk for testosterone heart attacks, strokes and other side effects by visiting Bernstein Liebhard LLP’s website.
Free, no-obligation legal consultations can be obtained by calling 800-511-5092.

*http://reuters.com/article/2014/09/17/us-usa-health-testosterone-idUSKBN0HC2C320140917, Reuters, September 17, 2014

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.testosteronelawsuithub.com/
https://plus.google.com/115936073311125306742?rel=author

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Follow us on
Visit website